Companies / Aclaris Therapeutics, Inc. / Activity
Activity — Aclaris Therapeutics, Inc.
69 moves.
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Apr 23, 2026 | Leonard Braden Michael 10% owner | Sell | Common Stock | $1.36M | -300K -2.11% | 13,950,000 9.48% of shares | medium |
| Dec 31, 2025 | Loerop James Executive | Other | Common Stock | $102.3K | -34K -19.20% | 143,062 0.10% of shares | low |
| Feb 3, 2026 | Walker Neal CEO | Other | Common Stock | $64.6K | -19K -1.19% | 1,543,886 1.05% of shares | low |
| Dec 31, 2025 | Balthaser Kevin Executive | Other | Common Stock | $60.0K | -20K -11.98% | 146,424 0.10% of shares | low |
| Feb 1, 2025 | Loerop James Executive | Other | Common Stock | $39.6K | -16K -13.46% | 102,773 0.07% of shares | low |
| Feb 1, 2025 | Loerop James Executive | Other | Common Stock | $39.6K | -16K -13.46% | 102,773 0.07% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Other | Common Stock | $37.5K | -11K -5.68% | 177,322 0.12% of shares | low |
| Jan 2, 2026 | Walker Neal CEO | Other | Common Stock | $28.7K | -10K -0.66% | 1,499,022 1.02% of shares | low |
| Feb 3, 2026 | Balthaser Kevin Executive | Other | Common Stock | $22.4K | -6K -3.36% | 185,755 0.13% of shares | low |
| Feb 3, 2026 | Loerop James Executive | Other | Common Stock | $20.6K | -6K -3.00% | 192,260 0.13% of shares | low |
| Jan 2, 2026 | Loerop James Executive | Other | Common Stock | $17.8K | -6K -3.83% | 155,041 0.11% of shares | low |
| Feb 1, 2026 | Balthaser Kevin Executive | Other | Common Stock | $17.5K | -5K -2.85% | 170,179 0.12% of shares | low |
| Jan 2, 2026 | Balthaser Kevin Executive | Other | Common Stock | $12.8K | -4K -2.71% | 160,413 0.11% of shares | low |
| Jan 1, 2026 | Balthaser Kevin Executive | Other | Common Stock | $6.8K | -2K -1.46% | 151,674 0.10% of shares | low |
| Mar 1, 2026 | Balthaser Kevin Executive | Other | Common Stock | $1.9K | -677 -0.36% | 187,453 0.13% of shares | low |
| Jun 5, 2026 | Gowen Maxine Director | Exercise | Restricted Stock Units | — | -12K -100.00% | 0 0.00% of shares | low |
| Jun 4, 2026 | Gowen Maxine Director | Grant | Restricted Stock Units | — | +11K | 10,987 <0.01% of shares | low |
| Jun 4, 2026 | Gowen Maxine Director | Grant | Stock Option (Right to Buy) | — | +42K | 42,350 0.03% of shares | low |
| Jun 5, 2026 | Gowen Maxine Director | Exercise | Common Stock | — | +12K +53.23% | 33,334 0.02% of shares | low |
| Jun 5, 2026 | Milano Vincent Director | Exercise | Restricted Stock Units | — | -12K -100.00% | 0 0.00% of shares | low |
| Jun 4, 2026 | Milano Vincent Director | Grant | Restricted Stock Units | — | +11K | 10,987 <0.01% of shares | low |
| Jun 4, 2026 | Milano Vincent Director | Grant | Stock Option (Right to Buy) | — | +42K | 42,350 0.03% of shares | low |
| Jun 5, 2026 | Milano Vincent Director | Exercise | Common Stock | — | +12K +66.87% | 28,896 0.02% of shares | low |
| Jun 5, 2026 | Schiff Andrew N Director | Exercise | Restricted Stock Units | — | -12K -100.00% | 0 0.00% of shares | low |
| Jun 4, 2026 | Schiff Andrew N Director | Grant | Restricted Stock Units | — | +11K | 10,987 <0.01% of shares | low |
| Jun 4, 2026 | Schiff Andrew N Director | Grant | Stock Option (Right to Buy) | — | +42K | 42,350 0.03% of shares | low |
| Jun 5, 2026 | Schiff Andrew N Director | Exercise | Common Stock | — | +12K +82.95% | 25,540 0.02% of shares | low |
| Feb 2, 2026 | Loerop James Executive | Grant | Employee Stock Option (Right to Buy) | — | +342K | 341,900 0.23% of shares | low |
| Feb 2, 2026 | Loerop James Executive | Grant | Restricted Stock Units | — | +98K | 97,700 0.07% of shares | low |
| Feb 3, 2026 | Loerop James Executive | Exercise | Restricted Stock Units | — | -21K -25.00% | 62,625 0.04% of shares | low |
| Feb 3, 2026 | Loerop James Executive | Exercise | Common Stock | — | +21K +11.77% | 198,197 0.13% of shares | low |
| Jan 2, 2026 | Loerop James Executive | Exercise | Restricted Stock Units | — | -18K -49.25% | 18,700 0.01% of shares | low |
| Dec 31, 2025 | Loerop James Executive | Exercise | Restricted Stock Units | — | -74K -100.00% | 0 0.00% of shares | low |
| Jan 2, 2026 | Loerop James Executive | Exercise | Common Stock | — | +18K +12.69% | 161,212 0.11% of shares | low |
| Dec 31, 2025 | Loerop James Executive | Exercise | Common Stock | — | +74K +71.39% | 177,056 0.12% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Restricted Stock Units | — | -15K -33.33% | 29,500 0.02% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Resticted Stock Units | — | -8K -50.00% | 7,500 <0.01% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Restricted Stock Units | — | -11K -100.00% | 0 0.00% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Common Stock | — | +15K +8.51% | 188,008 0.13% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Common Stock | — | +8K +4.52% | 173,258 0.12% of shares | low |
| Feb 1, 2026 | Loerop James Executive | Exercise | Common Stock | — | +11K +7.28% | 165,758 0.11% of shares | low |
| Feb 2, 2026 | Walker Neal CEO | Grant | Employee Stock Option (Right to Buy) | — | +962K | 961,700 0.65% of shares | low |
| Feb 2, 2026 | Walker Neal CEO | Grant | Restricted Stock Units | — | +275K | 274,800 0.19% of shares | low |
| Feb 3, 2026 | Walker Neal CEO | Exercise | Restricted Stock Units | — | -63K -25.00% | 190,425 0.13% of shares | low |
| Feb 3, 2026 | Walker Neal CEO | Exercise | Common Stock | — | +63K +4.23% | 1,562,497 1.06% of shares | low |
| Jan 2, 2026 | Walker Neal CEO | Exercise | Restricted Stock Units | — | -29K -49.25% | 30,034 0.02% of shares | low |
| Jan 2, 2026 | Walker Neal CEO | Exercise | Common Stock | — | +29K +1.97% | 1,508,974 1.03% of shares | low |
| Mar 1, 2026 | Balthaser Kevin Executive | Exercise | Restricted Stock Units | — | -2K -100.00% | 0 0.00% of shares | low |
| Mar 1, 2026 | Balthaser Kevin Executive | Exercise | Common Stock | — | +2K +1.28% | 188,130 0.13% of shares | low |
| Feb 2, 2026 | Kolbeck Roland Wilhelm Executive | Grant | Employee Stock Option (Right to Buy) | — | +335K | 334,900 0.23% of shares | low |